We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 950

Corporate Crime Update - March 2016 - United States
  • Herbert Smith Freehills LLP
  • China, Cuba, USA, Uzbekistan
  • March 31 2016

We reported in December that VimpelCom, the Dutch telecommunications company, made $900 million Accounting provision relating to bribery


美国的医疗器械知识产权保护 -中国公司的应对策略
  • Han Kun Law Offices
  • China, USA
  • March 28 2016

对那些在美国市场推出医疗器械产品的中国企业而言保护产品知识产权的秘密在于理解所有 124 可行条件125 选择最适合贵司医疗器械的知识产权保护类型十分


Global Privacy & Cybersecurity Update, Issue 9 - March 2016
  • Jones Day
  • Belgium, Brazil, Canada, China, USA, Japan, Mexico, Netherlands, Peru, Spain, Taiwan, Colombia, European Union, France, Germany, Hong Kong, Italy
  • March 17 2016

For decades, EU data protection rules have set some of the world's highest standards of data protection and are currently undergoing significant


The coenzyme Q10 “saga”
  • HFG Law & Intellectual Property
  • China
  • January 11 2016

In the fast-evolving world of food and health-food regulation, two recent court decisions deserve our attention as they rule in opposite direction a


Trademark Invalidation through Administrative Procedure
  • CCPIT Patent & Trademark Law Office
  • China
  • January 6 2016

Siemens, a German multinational conglomerate company, is one of the world's most prominent makers of medical diagnostics equipment, including CT, MR


Chinese pharma company fined for refusal to supply downstream competitors
  • Hogan Lovells
  • China
  • December 23 2015

On 22 December 2015, the State Administration for Industry and Commerce ("SAIC") published the decision of its local branch in Chongqing ("Chongqing


Insight into recent PRB decisions on pharmaceutical biotech inventions
  • Peksung Intellectual Property Ltd
  • China
  • December 11 2015

The Patent Reexamination Board (hereinafter referred to as the PRB) is an organization under the SIPO (State Intellectual Property Office) of China


News and cases from China: August - September 2015
  • Rouse
  • China
  • October 29 2015

Recently, the National Copyright Administration issued Implementing Measures for the Copyright Administrative Penalties (Revision Draft for Comment


吉利德丙肝药sovaldi最新专利申请遭中国拒绝
  • Beijing Sanyou Intellectual Property Agency Ltd
  • China
  • September 11 2015

根据美国游说组织I-MAK消息吉利德公司的重磅级丙肝药物专利申请遭到中国SIPO拒绝这是在I-MAK提出专利授予前异议后做出的决定I-MAK还联合其他公益性组织对该药物在欧盟印度和俄罗斯等其他市场的专利申请发起挑战索非布韦核心专利此前已经在印度和埃及遭到拒绝


China’s national antitrust authority fights administrative monopoly in Provincial Government drug procurement programs
  • Sidley Austin LLP
  • China
  • September 7 2015

On August 17, 2015, one of China's antitrust enforcement authorities, the National Development & Reform Commission (NDRC), issued a letter to the